106 related articles for article (PubMed ID: 1546774)
1. The validity of self-reported HIV antibody test results.
McCusker J; Stoddard AM; McCarthy E
Am J Public Health; 1992 Apr; 82(4):567-9. PubMed ID: 1546774
[TBL] [Abstract][Full Text] [Related]
2. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users.
Macalino GE; Celentano DD; Latkin C; Strathdee SA; Vlahov D
AIDS Educ Prev; 2002 Oct; 14(5):367-78. PubMed ID: 12413183
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
Friedman SR; Jose B; Deren S; Des Jarlais DC; Neaigus A
Am J Epidemiol; 1995 Oct; 142(8):864-74. PubMed ID: 7572963
[TBL] [Abstract][Full Text] [Related]
4. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
[TBL] [Abstract][Full Text] [Related]
6. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
7. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users.
Latkin CA; Vlahov D
Addiction; 1998 Aug; 93(8):1191-7. PubMed ID: 9813900
[TBL] [Abstract][Full Text] [Related]
8. Concurrence of drug users' self-report of current HIV status and serotest results.
Strauss SM; Rindskopf DM; Deren S; Falkin GP
J Acquir Immune Defic Syndr; 2001 Jul; 27(3):301-7. PubMed ID: 11464152
[TBL] [Abstract][Full Text] [Related]
9. Preference for sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm.
Käll K; Nilsonne A
AIDS Care; 1995; 7(2):171-88. PubMed ID: 7619871
[TBL] [Abstract][Full Text] [Related]
10. Behavioural patterns and HIV infection among drug using transvestites practising prostitution in Rome.
Gattari P; Spizzichino L; Valenzi C; Zaccarelli M; Rezza G
AIDS Care; 1992; 4(1):83-7. PubMed ID: 1562634
[TBL] [Abstract][Full Text] [Related]
11. Sentinel testing for the human immunodeficiency virus antibody at the Murray Street Clinic, Perth, Western Australia.
Kelly H; Sesnan K
Int J STD AIDS; 1991; 2(5):339-41. PubMed ID: 1958718
[TBL] [Abstract][Full Text] [Related]
12. HIV seropositivity in inner-city alcoholics.
Schleifer SJ; Keller SE; Franklin JE; LaFarge S; Miller SI
Hosp Community Psychiatry; 1990 Mar; 41(3):248-9, 254. PubMed ID: 2312072
[No Abstract] [Full Text] [Related]
13. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients.
Nahass RG; Weinstein MP; Bartels J; Gocke DJ
J Infect Dis; 1990 Oct; 162(4):967-70. PubMed ID: 2401795
[TBL] [Abstract][Full Text] [Related]
14. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
15. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
[TBL] [Abstract][Full Text] [Related]
16. Injecting drug use, characteristics of significant others, and HIV-risk behaviors.
Price RK; Cottler LB; Mager D; Murray KS
NIDA Res Monogr; 1995; 151():38-59. PubMed ID: 8742760
[No Abstract] [Full Text] [Related]
17. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
Nicolosi A; Leite ML; Musicco M; Molinari S; Lazzarin A
Am J Epidemiol; 1992 Feb; 135(3):225-33. PubMed ID: 1312300
[TBL] [Abstract][Full Text] [Related]
18. Infants born to HIV infected mothers.
Thanasophon Y; Na Chiengmai P
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):3-5. PubMed ID: 1523476
[TBL] [Abstract][Full Text] [Related]
19. Heterosexually acquired human immunodeficiency virus infection in women in Copenhagen: sexual behavior and other risk factors.
Smith E; Kroon S; Gerstoft J; Kvinesdal B; Mathiesen LR
Int J STD AIDS; 1990 Nov; 1(6):416-21. PubMed ID: 2094403
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
